Health and Human Services Department, Food and Drug Administration
The Food and Drug Administration (FDA, Agency, or we) is announcing the withdrawal of the proposed rule entitled "Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products," which published in the Federal Register of December 27, 2024. FDA is taking this action in response to comments received during the comment period for the proposed rule that warrant further consideration and assessment prior to issuing final regulations to establish and require standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products pursuant to the Modernization of Cosmetics Regulation Act of 2022.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Food and Drug Administration 21 CFR Part 730 [Docket No. FDA-2023-N-4225] RIN 0910-AI82 AGENCY: Food and Drug Administration, Department of Health and Human Services. ( printed page 54604) ACTION: Proposed rule; withdrawal. SUMMARY: The Food and Drug Administration (FDA, Agency, or we) is announcing the withdrawal of the proposed rule entitled “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products,” which published in the Federal Register of December 27, 2024. FDA is taking this action in response to comments received during the comment period for the proposed rule that warrant further consideration and assessment prior to issuing final regulations to establish and require standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products pursuant to the Modernization of Cosmetics Regulation Act of 2022. DATES: The proposed rule published December 27, 2024 ( 89 FR 105490 ) is withdrawn as of November 28, 2025. FOR FURTHER INFORMATION CONTACT: Elizabeth Anderson, Senior Policy Analyst, Food and Drug Administration, 240-402-4565, QuestionsAboutMoCRA@fda.hhs.gov . SUPPLEMENTARY INFORMATION: In the Federal Register of December 27, 2024 ( 89 FR 105490 ), FDA issued the proposed rule entitled “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products” as part of its implementation of the Modernization of Cosmet…
Other Federal Register documents from the same docket.
Citation: 90 FR 54603
